Blueprint Medicines - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $93,331.73 -4.53%
Ethereum $3,398.43 +1.40%
BNB $630.40 -4.57%
Optimism $2.30 +5.28%
Arbitrum $0.91 +6.98%
Solana $233.08 -7.77%
Polygon $0.54 -3.51%
Cosmos $7.85 -9.56%
Avalanche $41.06 -1.32%

Bitcoin $93,331.73 -4.53%
Ethereum $3,398.43 +1.40%
BNB $630.40 -4.57%
Optimism $2.30 +5.28%
Arbitrum $0.91 +6.98%
Solana $233.08 -7.77%
Polygon $0.54 -3.51%
Cosmos $7.85 -9.56%
Avalanche $41.06 -1.32%

Blueprint Medicines

company

Investors

Number of Lead Investors

Number of Investors

4

15

Blueprint Medicines is funded by 15 investors. Partner Fund Management and Eight Roads Ventures are the most recent investors.

Investor Name	Lead Investor	Funding Round
Partner Fund Management	Yes	Series C
Eight Roads Ventures	Yes	Series Unknown
Casdin Capital	-	Series C
Cowen Group	-	Series C
Fidelity Biosciences	-	Series C
Nextech Invest	-	Series C
Perceptive Advisors	-	Series C
RA Capital Management	-	Series C
Redmile Group	-	Series C
Sabby Capital	-	Series C
Tavistock Life Sciences	-	Series C
Third Rock Ventures	-	Series C
Wellington Management	-	Series C
Biotechnology Value Fund	-	Series B
F-Prime Capital	-	Series B